Red Flag Warning Issued

Another blood pressure medication recalled over carcinogen concerns

EAST WINDSOR, N.J. – Another blood pressure medication has been recalled over concerns it could contain trace amounts of carcinogens.

The medication is manufactured by Aurobino Pharma USA, Inc. The recall is voluntary.

It affects 80 lots of Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets, USP and Valsartan Tablets USP.

If you take the drug, contact your doctor.

You can check out all the latest drug recalls here.

Six blood pressure medications have been recalled since November.

All have been found to have trace amounts of N-nitrosodiethylamine (NDEA) and are manufactured by different companies.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

1 Comment

Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.